Intermolecular

Intermolecular is a source for advanced materials discovery and understanding. The Company works closely with its customers using its High Productivity Combinatorial (HPC) platform to discover, to develop and characterize engineered materials for next generation high-technology products. Good decisions require good data, and that’s where Intermolecular gives its partners a powerful competitive advantage – by generating high quality and extensive experimental data in less time. Intermolecular's solutions and services create value for its customers by enabling them to rapidly discover and create new options for mission-critical materials decisions.
Company Growth (employees)
Type
Public
HQ
San Jose, US
Founded
2004
Size (employees)
145 (est)-17%
Intermolecular was founded in 2004 and is headquartered in San Jose, US

Key People at Intermolecular

Tony Chiang, Ph.D

Tony Chiang, Ph.D

CTO

Intermolecular Office Locations

Intermolecular has an office in San Jose
San Jose, US (HQ)
3011 N 1st St

Intermolecular Data and Metrics

Intermolecular Financial Metrics

Intermolecular's revenue was reported to be $47.3 m in FY, 2016 which is a 4% increase from the previous period.
$, USD

Revenue (FY, 2016)

47.3 m

Revenue growth (FY, 2015 - FY, 2016), %

4%

Gross profit (FY, 2016)

31.5 m

Gross profit margin (FY, 2016), %

67%

Net income (FY, 2016)

(15.4 m)

EBIT (FY, 2016)

(15.9 m)

Market capitalization (23-Jun-2017)

46.9 m

Closing share price (23-Jun-2017)

1

Cash (31-Dec-2016)

5.8 m
Intermolecular's current market capitalization is $46.9 m.
$, USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

67.4 m47.7 m45.3 m47.3 m

Revenue growth, %

(29%)(5%)4%

Cost of goods sold

32.5 m24.7 m19.3 m15.8 m

Gross profit

34.9 m23 m26 m31.5 m

Gross profit Margin, %

52%48%57%67%

Operating expense total

43 m44.1 m46.7 m47.3 m

EBIT

(8 m)(21 m)(20.7 m)(15.9 m)

EBIT margin, %

(12%)(44%)(46%)(34%)

Interest expense

830 k682 k267 k173 k

Interest income

173 k

Pre tax profit

(8.8 m)(21.8 m)(21 m)(15.4 m)

Income tax expense

17 k7 k8 k7 k

Net Income

(8.8 m)(21.8 m)(21 m)(15.4 m)
$, USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

72.1 m21.8 m11.7 m5.8 m

Inventories

2.2 m1.8 m1.6 m1.4 m

Current Assets

81.4 m72.2 m43.1 m32.3 m

PP&E

28.5 m19.1 m15.7 m11 m

Total Assets

124.5 m105.4 m69.7 m53.2 m

Accounts Payable

2.2 m862 k848 k309 k

Current Liabilities

14 m10.1 m10.2 m5 m

Additional Paid-in Capital

194.9 m202.1 m209 m213.3 m

Retained Earnings

(110.1 m)(131.9 m)(152.9 m)(168.3 m)

Total Equity

56.1 m45 m

Financial Leverage

1.2 x1.2 x
$, USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(8.8 m)(21.8 m)(21 m)(15.4 m)

Depreciation and Amortization

10.9 m

Accounts Receivable

1.7 m1.1 m

Inventories

2.2 m1.6 m1.6 m

Accounts Payable

2.2 m(635 k)848 k(493 k)

Cash From Operating Activities

(6.2 m)(1.9 m)(10.1 m)(5.4 m)

Purchases of PP&E

(2.8 m)(2.4 m)

Cash From Investing Activities

(47.7 m)(1.2 m)

Cash From Financing Activities

(810 k)701 k

Interest Paid

666 k9 k
Y, 2016

Financial Leverage

1.2 x

Intermolecular Market Value History

Intermolecular Median Salaries

Source: 17 public H-1B filings from Intermolecular

Intermolecular Online and Social Media Presence

Intermolecular Company Life and Culture

You may also be interested in